SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-367435
Filing Date
2017-12-12
Accepted
2017-12-12 16:02:33
Documents
6
Period of Report
2017-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d512453d8k.htm 8-K 20059
2 EX-1.1 d512453dex11.htm EX-1.1 161153
3 EX-5.1 d512453dex51.htm EX-5.1 4913
4 EX-99.1 d512453dex991.htm EX-99.1 9662
5 GRAPHIC g512453g1212213840096.jpg GRAPHIC 2240
6 GRAPHIC g512453g1212214145346.jpg GRAPHIC 4174
  Complete submission text file 0001193125-17-367435.txt   206377
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 171251803
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1